Zolmax Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Analysts at HC Wainwright upped their Q3 2024 earnings per share (EPS) estimates for shares of Ikena Oncology in a note issued to investors on...\n more…
Ticker Report Ikena Oncology, Inc. (NASDAQ:IKNA - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2024 EPS estimates for shares of Ikena Oncology in a report released on Monday, August 12th. HC...\n more…
Ticker Report Ikena Oncology (NASDAQ:IKNA - Get Free Report)s stock had its "buy" rating restated by research analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nIKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024.\nThe post IKNA...\n more…
Globe Newswire Strong financial position with $145 million in cash and investments at close of second quarterBOSTON, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena, Company ) today...\n more…